Status:

COMPLETED

Bioequivalence Evaluation of Two Fixed-dose Combination of Lisinopril 10mg/Levamlodipine Besylate 5mg in Healthy Chinese Subjects

Lead Sponsor:

The Affiliated Hospital of Qingdao University

Conditions:

Therapeutic Equivalency

Eligibility:

All Genders

18+ years

Phase:

PHASE1

Brief Summary

The bioavailability of compound lisinopril tablets (specification: lisinopril 10mg / amlodipine 5mg) developed by Sichuan shangrui biomedical Co., Ltd. was compared with that of reference compound lis...

Eligibility Criteria

Inclusion

  • \- 1.Healthy male and female aged over 18years 2.Subjects willing to provide written informed consent and to adhere to protocol requirements 3.Subject's weight within normal range according to normal values for Body Mass Index (19.00 to 26.00 kg/m2 (both inclusive)), males with minimum of 50 kg weight, females with minimum of 45kg weight.
  • Subjects have not clinically significant abnormalities, including vital signs, physical examinations, laboratory tests, and ECG as determined by clinical examination

Exclusion

  • History or presence of significant cardiovascular, Urogenital, pulmonary, hepatic, renal, gastrointestinal, endocrine, immunological, dermatological, neurological or psychiatric disease or disorder 2.Allergic constitution(Allergic to two or more substances) or hypersensitivity to investigational product 3.History or presence of significant gastrointestinal inflammation /ulcer. or other medical history affecting drug absorption 4.Use of any drugs or herbal medicine within 14 days prior to the first dose 5.Can not follow approved birth control methods (a double barrier method) from the screening(Female subjects from two weeks prior to the screening) till 3 months after the last dose

Key Trial Info

Start Date :

October 12 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 20 2019

Estimated Enrollment :

92 Patients enrolled

Trial Details

Trial ID

NCT04885660

Start Date

October 12 2018

End Date

November 20 2019

Last Update

May 13 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Affiliated Hospital of Qingdao University

Qingdao, Shandong, China, 266003